ARTICLES BY DOMINIC GALANTE
-
![Why Pharma Needs A New Approach To Patient Engagement In Drug Development]( "Why Pharma Needs A New Approach To Patient Engagement In Drug Development")
Why Pharma Needs A New Approach To Patient Engagement In Drug Development9/21/2017Pharmaceutical companies face many challenges: developing life-changing products that meet the needs of patients, physicians, and payers; adhering to regulatory standards; and managing health technology and payer scrutiny, all while trying to satisfy investors. As drug prices seem to be continually rising, many health plans are shifting more of the cost-sharing burden to patients. As a result, the patient is becoming more of a “consumer” in the traditional sense.
Dominic Galante
Dominic Galante, M.D., is chief medical officer of quality and population health solutions at Precision for Value. He is a leading authority in managed care, pharmaceutical markets, clinical quality management, healthcare provider performance-based delivery and reimbursement models, healthcare system migrations, community health alliances, organizational change, communications, and medical marketing.